Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies

K Cheung, SS Lee, M Raman - Clinical Gastroenterology and Hepatology, 2012 - Elsevier
Malnutrition is prevalent among cirrhotic patients and is an important prognostic factor.
Etiologic factors include hypermetabolism, malabsorption, altered nutrient metabolism, and …

[PDF][PDF] A practical approach to nutritional screening and assessment in cirrhosis

P Tandon, M Raman, M Mourtzakis, M Merli - Hepatology, 2017 - Wiley Online Library
Malnutrition is one of the most common complications of cirrhosis, associated with an
increased risk of morbidity and mortality. As a potentially modifiable condition, it is of …

The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance

JA Parnell, M Raman, KP Rioux… - Liver International, 2012 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) and the more severe non‐alcoholic
steatohepatitis (NASH) represent a spectrum of diseases involving hepatic fat accumulation …

Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease

M Raman, I Ahmed, PM Gillevet, CS Probert… - Clinical …, 2013 - Elsevier
BACKGROUND & AIMS: The histopathology of nonalcoholic fatty liver disease (NAFLD) is
similar to that of alcoholic liver disease. Colonic bacteria are a source of many metabolic …

Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study

JP Allard, E Aghdassi, S Mohammed, M Raman… - Journal of …, 2008 - Elsevier
BACKGROUND/AIMS: Low hepatic n− 6 and n− 3 polyunsaturated fatty acid (PUFA) may
contribute to steatosis and steatohepatitis and can be affected by diet and oxidative stress …

Obesity: a review of pathogenesis and management strategies

B Kaila, M Raman - Canadian journal of gastroenterology, 2008 - hindawi.com
The prevalence of obesity in the developed world is increasing. Approximately 23% of adult
Canadians (5.5 million people) are obese. Obesity is associated with an increased risk of …

[HTML][HTML] Parenteral nutrition and lipids

M Raman, A Almutairdi, L Mulesa, C Alberda, C Beattie… - Nutrients, 2017 - mdpi.com
Lipids have multiple physiological roles that are biologically vital. Soybean oil lipid
emulsions have been the mainstay of parenteral nutrition lipid formulations for decades in …

Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: a systematic review with meta-analysis

A D'Silva, DE Fox, Y Nasser, JK Vallance… - Clinical …, 2022 - Elsevier
Background and Aims Inflammatory bowel disease (IBD) is a chronic relapsing and remitting
disease with high morbidity, substantial health care costs, and increasing incidence. Fatigue …

Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer

M Raman, AN Milestone, JRF Walters… - Therapeutic …, 2011 - journals.sagepub.com
Over the past 5 years, there has been a rapid resurgence of interest in vitamin D outside of
its traditional role in metabolic bone disease. Some nontraditional roles ascribed to vitamin …

Sarcopenic obesity in cirrhosis—the confluence of 2 prognostic titans

T Eslamparast, AJ Montano‐Loza, M Raman… - Liver …, 2018 - Wiley Online Library
Sarcopenia and obesity are 2 major health conditions with a growing prevalence in
cirrhosis. The concordance of these 2 conditions, sarcopenic obesity, is associated with …